These results suggested that SphK1 might be involved in ovarian cancer angiogenesis and raised the possibility that SphK1 might serve as a novel target to block tumor-associated angiogenesis in ovarian cancer. This evidence concerns the gene SPHK1 and ovarian carcinoma.